Close Menu

Population Genetics Technologies

The HIV test is the first of several NGS-based infectious disease tests the company plans to develop, with a hepatitis C virus test following close behind.

The tests will use PGT's VeriTag technology in order to detect drug-resistant mutations at the .1 percent level. 

NEW YORK (GenomeWeb News) – Population Genetics Technologies today said that it has exclusively licensed patent rights covering its VeriTag technology to Agilent Technologies.

NEW YORK (GenomeWeb News) – Population Genetics Technologies has assigned to New England Biolabs the exclusive rights to a patent covering methods related to next-generation sequencing library preparation, the two firms said today.

NEW YORK (GenomeWeb News) – Sequenom said this week that the California Technology Assessment Forum has completed an independent evaluation of the cell-free fetal DNA technology used in the Sequenom Center for Molecular Medicine's MaterniT21 Plus laboratory-developed test.

NEW YORK (GenomeWeb News) – Population Genetics Technologies said today that it has partnered with the University of Cambridge's Autism Research Centre to study variants in two genes that previously have been associated with Asperger syndrome.

Fluidigm of South San Francisco, Calif., has received US Patent No. 8,168,139, "Recirculating fluidic network and methods for using the same." The patent provides a variety of microfluidic devices and methods for conducting assays and syntheses.

The deal gives Quintiles access to PGT’s genomic data-analysis technology, and is in line with Quintiles' ongoing efforts to expand its pharmacogenomics research capabilities.

The companies' first project will be a renal cancer clinical trial for an undisclosed Quintiles client. The partners aim to identify genetic markers that are predictive of adverse events and efficacy.

The firms will jointly identify opportunities to apply large-scale genomic analyses to test clinical hypotheses and correlate biomarkers of disease prognosis and drug responsiveness.

Pages

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.